Brain gene APOE2 shields cells from DNA damage

The gene in question is a variant of APOE, which encodes a protein involved in fat transport in the blood and brain. There are three main variants: APOE2, APOE3 and APOE4. Carriers of APOE4 face a significantly elevated risk of Alzheimer’s disease. Carriers of APOE2 appear to be protected. Until now, the reasons for this remained largely unclear.

The researchers show that APOE2 helps brain cells limit DNA damage. Neurons from APOE2 carriers show fewer breaks and less damage in their genetic material. Those cells also recover more quickly when exposed to stress. Both mechanisms are directly relevant to aging: DNA damage accumulates as we grow older, and the capacity to repair it declines.

A new path toward treatment

The finding opens a potential route to therapies. Understanding how APOE2 provides its protective effect could allow researchers to mimic it in people who carry APOE4 or who simply face an elevated Alzheimer’s risk. That remains a long road from mechanistic insight to a working treatment, but it provides a concrete starting point.

Genetic risk is not destiny

The study also underscores that genetic risk is not an inevitable fate. APOE4 raises the risk, but not everyone who carries it develops Alzheimer’s. The biological protection mechanisms activated by APOE2 could, in principle, be mimicked or enhanced even in people without the favorable variant.

For now, these are cell-level findings. Whether the same effect holds in living humans, and at what scale, requires further research. The researchers describe this as a new direction, not a proven treatment.

Read the original article